Skip to content
lifestyle.projectdiaspora.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lexaria Bioscience Corp.
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
May 6, 2026
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
May 5, 2026
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales
May 4, 2026
Lexaria’s New Animal Study Aims to Expand Valuable Intellectual Property
May 4, 2026
Lexaria Applauds Eli Lilly’s Foundayo(TM) Drug Approval
May 3, 2026
Lexaria to Begin New Human Clinical Study in GLP-1
May 2, 2026
Lexaria’s Robust Patent Portfolio Continues to Grow
May 1, 2026
Lexaria Announces New R&D Plans for 2026
April 28, 2026
Lexaria Announces Positive Final Results From Human Pilot Study #5
February 11, 2026
←
Previous Page
1
2